Cecilia CS Yeung, MDAssociate Member, Fred Hutchinson Cancer Research Center, Clinical Research DivisionAssistant Professor, Dept of Pathology, University of WashingtonMedical Director, Molecular Oncology Laboratory, Fred Hutchinson Cancer Research CenterPathologist, Seattle Cancer Care Alliance
Objectives:1. Discuss recent findings impacting our understanding of MDS and pre-MDS states2. Recapitulate new changes to classification in the 2016 WHO3. Describe on a preliminary level how pathology helps discover immune therapy evasion mechanism
Speaker disclosures: Dr. Cecilia Yeung discloses a consulting, speaking and teaching relationship with ArcherDx.
2018-2019 Laboratory Medicine Grand Rounds Planning Committee Disclosures:
The following members have no financial or other relationship with any commercial interest in the past twelve months: Sindhu Cherian, MD; Ashley Eckel, MD, PhD; Rhona Jack, PhD; Nik Krumm, MD, PhD; Amalia Magaret, PhD; Joe Rutledge, MD; Dan Sabath, MD, PhD, Brian Shirts, MD, PhD and Mark Wener, MD, PhD.
Planning member disclosures, continued: Noah Hoffman, MD, PhD discloses a consulting, speaking and teaching relationship and an advisory committee or review council relationship with Bio-Rad; Sean Murphy, MD, PhD discloses being a major stock shareholder in Sound Vaccines Inc. and grant/research support from Novartis Inc.
Grant Acknowledgement: None